Chinese biopharmaceutical company Shanghai Junshi Biosciences Co. has filed for a US$414 million initial public offering in Hong Kong, according to a security filing released today. Junshi Biosciences will offer 158.9 million shares with a price per share ranging between HK$19.38 (US$2.48) and HK$20.38 (US$2.61). The shares will commence being traded on December 24. Founded in […]

Chinese Biopharmaceutical Firm Junshi Biosciences Targets $414M IPO In Hong Kong appeared first on China Money Network.